Skip to main content
BMJ Open logoLink to BMJ Open
. 2022 Jan 7;12(1):e049351. doi: 10.1136/bmjopen-2021-049351

Joint effects of self-reported sleep and modifiable physical activity on risk of dyslipidaemia in women aged 45–55 years: a cross-sectional study

Sha Du 1,#, Yuenan Su 1,#, Dongxue Zhang 1, Jing Wu 2, Huiqiu Zheng 3, Xuemei Wang 1,
PMCID: PMC8744097  PMID: 34996783

Abstract

Objectives

Modifiable physical activity (PA) plays an important role in dyslipidaemia risk in middle-aged women with sleep problems, especially perimenopausal women. We aimed to explore the joint effects of sleep and PA on the risk of dyslipidaemia in women aged 45–55 years, and the extent to which PA moderated the effect of sleep on the risk of dyslipidaemia.

Design

A cross-sectional study.

Setting

This study was based on the survey of Chronic Disease and Nutrition Monitoring in Adults in Inner Mongolia in 2015.

Participants

721 women aged 45–55 years were included.

Outcome measurement

PA was measured by the Global Physical Activity Questionnaire. Sleep was measured by questionnaire formulated by the Chinese Center for Disease Control and Prevention. Multivariate logistic regression analyses were performed to determine the joint effects of sleep and PA on dyslipidaemia risk. OR and 95% CI were reported.

Results

Among all participants, 60.6% had sleep problems, 29.0% had low PA and 41.1% had dyslipidaemia. Women with sleep problems had higher dyslipidaemia risk than women without sleep problems, irrespective of low, moderate or high PA, with OR (95% CI) of 4.24 (2.40 to 7.49), 3.14 (1.80 to 5.49) and 2.04 (1.20 to 3.48), respectively. PA could not completely attenuate the negative association between sleep and dyslipidaemia risk. With PA increased from low to high, the OR of dyslipidaemia decreased by 2.20. Women with sleep problems and low PA had higher risks of high total cholesterol, high triglyceride, low high-density lipoprotein cholesterol and high low-density lipoprotein cholesterol than women without sleep problems and high PA, with OR (95% CI) of 2.51 (1.18 to 5.35), 2.42 (1.23 to 4.74), 2.88 (1.44 to 5.74) and 2.52 (1.12 to 5.70), respectively.

Conclusions

Among women aged 45–55 years, the joint effects of self-reported sleep and PA on dyslipidaemia risk were more marked for sleep than for PA. Modifiable PA is a widely accessible and effective intervention to reduce the dyslipidaemia risk in women with sleep problems, particularly among perimenopausal women.

Keywords: lipid disorders, public health, primary care


Strengths and limitations of this study.

  • This study was based on the survey of Chronic Disease and Nutrition Monitoring in Adults, covered urban, agricultural and pastoral areas in Inner Mongolia. The participants were recruited consecutively used multistage stratified cluster random sampling, which were generally representative.

  • The study explored the joint effects of sleep and physical activity (PA) on the risk of dyslipidaemia in women aged 45–55 years, and the extent to which PA moderated the effect of sleep on the risk of dyslipidaemia.

  • Due to the cross-sectional design of the study, associations between self-reported sleep, PA and the risk of dyslipidaemia can be inferred but not causality.

Introduction

Dyslipidaemia is a major risk factor for cardiovascular disease.1 2 Elevated low-density lipoprotein cholesterol (LDL-C) accounted for 4.32 million deaths and 94.9 million disability-adjusted life years worldwide in 2017.3 Furthermore, elevated total cholesterol (TC) and triglyceride (TG) can increase the risk of type 2 diabetes mellitus,4 and reduced high-density lipoprotein cholesterol (HDL-C) can worsen the outcomes of patients with coronary heart disease.5

Dyslipidaemia includes elevated TC, elevated TG, elevated LDL-C and low HDL-C.6 Risk factors of dyslipidaemia includes age,7 low oestrogen levels,8 sleep disorder,9 smoking10 and insufficient aerobic exercise.11 Among perimenopausal women, aged 45–55 years,12 13 with decreasing oestrogen levels, the incidence of dyslipidaemia has increased significantly.14 15 The prevalence of dyslipidaemia was reported to be 38.7% among middle-aged and elderly women in China.16 Thus, identifying modifiable risk factors for dyslipidaemia is very important for public health.

Sleep problems tend to become more common in middle-aged and elderly women, and include difficulty in falling asleep, early awakening and awakening during the night.17–20 Poor sleep quality was significantly associated with an increased risk of dyslipidaemia.21 22 Poor sleep quality was also correlated with high TG and TC,23 but negatively correlated with HDL-C.24 A potential mechanism for the associations may be that women in the perimenopausal period, had gradually decreasing hormone levels when their sleep problems occurred, leading to dyslipidaemia.25

Physical activity (PA) is a modifiable and conventional influencing factor for dyslipidaemia. Several studies demonstrated that low PA had adverse effects on prevalence of dyslipidaemia.16 26 HDL-C was found to increase after PA intervention.27 PA led to high energy consumption, which reduced the level of TG.28 For patients with dyslipidaemia, increased PA significantly reduced their risk of death.29

There is some evidence that the association between sleep and PA is bidirectional. Moderate-to-vigorous intensity PA was associated with better sleep quality.30 31 Poor sleep quality limited PA,32 and sleep problems were associated with insufficient PA.33 Therefore, the mechanism for the effects of sleep and PA on dyslipidaemia is very complex.

PA is a modifiable lifestyle factor, but sleep problems are important symptoms of neurological diseases that are difficult to regulate.34Casas et al35 reported significant linear trends in TG and HDL-C among leisure-time activity and sleep quality categories in middle-aged women. However, little is known about the associations of PA, including occupational, transition and leisure-time activity, and sleep with risk of dyslipidaemia in women aged 45–55 years. This study aimed to explore the joint effects of sleep and PA on the risk of dyslipidaemia in women aged 45–55 years, and the extent to which PA moderated the effect of sleep on the risk of dyslipidaemia to provide some effective suggestions for the management of dyslipidaemia in perimenopausal women.

Methods

Design and setting of the study

The data for this cross-sectional study were collected from the survey of Chronic Disease and Nutrition Monitoring in Adults in Inner Mongolia in 2015, conducted by the Chinese Center for Disease Control and Prevention (CDC). The survey was conducted across eight monitoring sites, covered urban, agricultural and pastoral areas in Inner Mongolia. Participants, aged ≥18 years were selected by multistage-stratified cluster random sampling. All participants received on-site investigations that included questionnaires, anthropometric measurements and fasting blood sample collections.

Women aged 45–55 years were enrolled in the present study (n=821). Subsequently, 100 women were excluded for missing weight, height or waist circumference data (n=25), missing serum lipid testing data (n=8), missing alcohol drinking data (n=1), reporting that they did not drink but indicating alcohol intake (n=32) and having mean total PA time exceeding 1440 min/day (n=34). Finally, a total of 721 women were included in the study.

Data collection

The questionnaire used in the study was from Chinese CDC and evaluated by experts, with high reliability and validity. General information including age, ethnicity, educational level, marital status and residence, lifestyle variables including smoking status, alcohol drinking status, sleep and PA, and history of dyslipidaemia were obtained by trained investigators through face-to-face interviews.

Anthropometric data including height, weight and waist circumference were measured by trained investigators. Fasting venous blood samples were collected by trained laboratory staff members.36

Measurements

Dyslipidaemia definition

Dyslipidaemia was defined as having any one of the following: high TC (serum TC ≥240 mg/dL), high TG (serum TG ≥200 mg/dL), high LDL-C (serum LDL-C ≥160 mg/dL), low HDL-C (serum HDL-C <40 mg/dL) and self-reported dyslipidaemia diagnosis.37

Sleep assessment

Self-reported sleep was measured by the following questions: during the past 30 days, for more than 3 days per week (including 3 days), did you have any one of the following problems: (1) snoring, asphyxiating or suffocating; (2) difficulty in falling asleep (more than 30 min); (3) midway wakefulness twice or more; (4) medication for at least 1 day to help sleep; and (5) waking up early and difficulty in falling asleep again. Participants could respond ‘yes’ or ‘no’. We defined sleep problems as at least one answer of ‘yes’. These similar questions of sleep assessment have used in previous studies.17 38

Assessment of PA

PA was collected using the Global Physical Activity Questionnaire (GPAQ).39 Different domain-specific PAs (work, transportation and recreational activities) were classified into moderate and vigorous intensity. For assessment of total PA, we calculated the metabolic equivalent (MET) minutes per week according to the GPAQ analysis guide40: MET-min/week = (moderate minutes×4.0 METs) + (vigorous minutes×8.0 METs). Total PA was categorised as low (0–1908 MET-min/week), moderate (1909–5129 MET-min/week) and high (≥5130 MET-min/week).41

Covariates

Covariates included age, ethnicity (Han/Mongolian/other minority), educational level (primary school or lower/junior high school/senior high school and above), marital status (single/married/others) and residence (rural/urban). Lifestyle variables included smoking status (yes/no) and alcohol drinking status (yes/no). Anthropometric data included height, weight and waist circumference (<85 cm, ≥85 cm). Body mass index was calculated as weight (kg)/height2 (m2) and categorised as normal or underweight (<24.0 kg/m2), overweight (24.0–27.9 kg/m2) or obese (≥28.0 kg/m2).42

Statistical analysis

Continuous variables were shown as mean±SD. Categorical variables were expressed as rate or proportion. The t-test, analysis of variance and χ2 test were used to analyse differences in sleep, PA and dyslipidaemia in the participants with different characteristics. Multivariate logistic regression analyses were conducted to examine the associations of sleep and PA with risk of dyslipidaemia. The results were reported as OR with 95% CI. We defined α=0.05 as the significance level, and two-tailed p<0.05 was considered to indicate statistical significance. All data analyses were performed using IBM SPSS Statistics V.19.0 (IBM Corp).

Patient and public involvement

This research was done without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient-relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.

Results

Demographic characteristics of the participants

Seven hundred and twenty-one women were included in this study and the mean age was 50.2 years (SD=2.8 years). Among all participants, 593 (82.2%) were Han ethnicity, 430 (61.0%) were from rural areas, 317 (44.0%) had primary school or lower educational level and the majority were married (96.8%). Six hundred and eleven (84.7%) were non-drinkers, 675 (93.6%) were non-smokers, 237 (32.9%) were normal or underweight and 425 (58.9%) had waist circumference <85 cm.

Four hundred and thirty-seven (60.6%) had sleep problems and 209 (29.0%) had low PA. There were significant differences in sleep among people with different age, smoking status, alcohol drinking status and residence status, and significant differences in PA among people with different educational level and residence (all p<0.05, table 1). There was no significant difference in PA between the different sleep groups (p>0.05, table 1).

Table 1.

Characteristics of sleep and physical activity in women

Sleep problems P value Physical activity P value
No (n=284) Yes (n=437) Low (n=209) Moderate (n=215) High (n=297)
Age (years) 49.8 (2.8) 50.5 (2.8) 0.001** 50.1 (2.9) 50.5 (2.9) 50.1 (2.8) 0.285
Ethnicity
Han 230 (38.8) 363 (61.2) 0.757 169 (28.5) 173 (29.2) 251 (42.3) 0.423
Mongolian 37 (41.6) 52 (58.4) 28 (31.5) 26 (29.2) 35 (39.3)
Other minority 17 (43.6) 22 (56.4) 12 (30.8) 16 (41.0) 11 (28.2)
Educational level
Primary school or lower 127 (40.1) 190 (59.9) 0.068 75 (23.7) 87 (27.4) 155 (48.9) 0.002**
Junior high school 87 (34.5) 165 (65.5) 79 (31.4) 78 (31.0) 95 (37.6)
Senior high school and above 70 (46.1) 82 (53.9) 55 (36.2) 50 (32.9) 47 (30.9)
Marital status
Singled 2 (66.7) 1 (33.3) 0.578 1 (33.3) 2 (66.7) 0 (0) 0.097
Married 275 (39.4) 423 (60.6) 205 (29.4) 203 (29.1) 290 (41.5)
Others 7 (35.0) 13 (65.0) 3 (15.0) 10 (50.0) 7 (35.0)
Smoking status
No 273 (40.4) 402 (59.6) 0.026* 197 (29.2) 204 (30.2) 274 (40.6) 0.440
Yes 11 (23.9) 35 (76.1) 12 (26.1) 11 (23.9) 23 (50.0)
Alcohol drinking status
No 253 (41.4) 358 (58.6) 0.009** 185 (30.3) 180 (29.5) 246 (40.3) 0.190
Yes 31 (28.2) 79 (71.8) 24 (21.8) 35 (31.8) 51 (46.4)
Residence
Rural 188 (42.7) 252 (57.3) 0.022* 121 (27.5) 120 (27.3) 199 (45.2) 0.020*
Urban 96 (34.2) 185 (65.8) 88 (31.3) 95 (33.8) 98 (34.9)
Body mass index
Normal or underweight 94 (39.7) 143 (60.3) 0.723 69 (29.1) 67 (28.3) 101 (42.6) 0.966
Overweight 132 (40.5) 194 (59.5) 93 (28.5) 101 (31.0) 132 (40.5)
Obese 58 (36.7) 100 (63.3) 47 (29.8) 47 (29.8) 64 (40.4)
Waist circumference (cm)
<85 163 (38.4) 262 (61.6) 0.495 119 (28.0) 132 (31.1) 174 (40.9) 0.639
≥85 121 (40.9) 175 (59.1) 90 (30.4) 83 (28.0) 123 (41.6)
Sleep problems
No 83 (29.2) 82 (28.9) 119 (41.9) 0.902
Yes 126 (28.8) 133 (30.4) 178 (40.7)

*p<0.05, **p<0.01.

Prevalence of dyslipidaemia and its components

The prevalence of dyslipidaemia in women with sleep problems was significantly higher than that of women without sleep problems (47.4% vs 31.3%; p<0.001). Women with sleep problems also had higher prevalence of high TC, high TG than women without sleep problems (14.2% vs7.7%, 23.3% vs 15.8%; all p≤0.05). Women with low PA had a higher prevalence of dyslipidaemia (49.8% vs 43.7% vs 33.0%; p=0.001), and low HDL-C (27.7% vs 23.3% vs 18.5%; p=0.049) compared with moderate or high PA. (table 2).

Table 2.

Prevalence of dyslipidaemia and its components in women

All Sleep problems P value Physical activity P value
No Yes Low Moderate High
Dyslipidaemia
No 425 (58.9) 195 (68.7) 230 (52.6) <0.001*** 105 (50.2) 121 (56.3) 199 (67.0) 0.001**
Yes 296 (41.1) 89 (31.3) 207 (47.4) 104 (49.8) 94 (43.7) 98 (33.0)
High TC
No 673 (88.3) 262 (92.3) 375 (85.8) 0.008** 177 (84.7) 188 (87.4) 272 (91.5) 0.052
Yes 84 (11.7) 22 (7.7) 62 (14.2) 32 (15.3) 27 (12.6) 25 (8.5)
High TG
No 574 (79.6) 239 (84.2) 335 (76.7) 0.015* 160 (76.7) 168 (78.1) 246 (82.8) 0.184
Yes 147 (20.4) 45 (15.8) 102 (23.3) 49 (23.3) 47 (21.9) 51 (17.2)
Low HDL-C
No 558 (77.4) 229 (80.6) 329 (75.3) 0.093 151 (72.3) 165 (76.7) 242 (81.5) 0.049*
Yes 163 (22.6) 55 (19.4) 108 (24.7) 58 (27.7) 50 (23.3) 55 (18.5)
High LDL-C
No 655 (90.8) 264 (93.0) 391 (89.5) 0.113 183 (87.6) 196 (91.2) 276 (92.9) 0.117
Yes 66 (9.2) 20 (7.0) 46 (10.5) 26 (12.4) 19 (8.8) 21 (7.1)

*p<0.05, **p<0.01, ***p<0.001.

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.

Independent effect of PA and sleep on dyslipidaemia and its components

In the multivariate logistic analyses, the effects of PA and sleep on risk of dyslipidaemia remained evident. Compared with women without sleep problems, the adjusted OR (95% CI) for dyslipidaemia, high TC and high TG in women with sleep problems were 2.15 (1.54 to 2.99), 1.81 (1.08 to 3.04) and 1.64 (1.10 to 2.46), respectively. Furthermore, compared with women with high PA, the adjusted OR (95% CI) for dyslipidaemia in women with low PA was 1.94 (1.32 to 2.84) (table 3).

Table 3.

Independent effect of physical activity and sleep on dyslipidaemia and its components

Model 1† P value Model 2‡ P value
OR (95% CI) OR (95% CI)
Dyslipidaemia
Physical activity
 High 1.00 (reference) <0.001*** 1.00 (reference) 0.002**
 Moderate 1.58 (1.10 to 2.27) 1.55 (1.06 to 2.27)
 Low 2.01 (1.40 to 2.89) 1.94 (1.32 to 2.84)
Sleep problems
 No 1.00 (reference) <0.001*** 1.00 (reference) <0.001***
 Yes 1.97 (1.44 to 2.70) 2.15 (1.54 to 2.99)
High TC
Physical activity
 High 1.00 (reference) 0.017* 1.00 (reference) 0.059
 Moderate 1.56 (0.88 to 2.78) 1.48 (0.83 to 2.65)
 Low 1.97 (1.13 to 3.43) 1.98 (1.13 to 3.47)
Sleep problems
 No 1.00 (reference) 0.009** 1.00 (reference) 0.025*
 Yes 1.97 (1.18 to 3.28) 1.81 (1.08 to 3.04)
High TG
Physical activity
 High 1.00 (reference) 0.076 1.00 (reference) 0.348
 Moderate 1.35 (0.88 to 2.10) 1.30 (0.82 to 2.06)
 Low 1.48 (0.95 to 2.29) 1.37 (0.87 to 2.17)
Sleep problems
 No 1.00 (reference) 0.015* 1.00 (reference) 0.015*
 Yes 1.62 (1.10 to 2.38) 1.64 (1.10 to 2.46)
Low HDL-C
Physical activity
 High 1.00 (reference) 0.014* 1.00 (reference) 0.083
 Moderate 1.33 (0.87 to 2.05) 1.32 (0.84 to 2.07)
 Low 1.69 (1.11 to 2.58) 1.65 (1.06 to 2.57)
Sleep problems
 No 1.00 (reference) 0.094 1.00 (reference) 0.073
 Yes 1.37 (0.95 to 1.97) 1.43 (0.97 to 2.10)
High LDL-C
Physical activity
 High 1.00 (reference) 0.043* 1.00 (reference) 0.092
 Moderate 1.27 (0.67 to 2.43) 1.38 (0.72 to 2.65)
 Low 1.87 (1.02 to 3.42) 1.98 (1.07 to 3.65)
Sleep problems
 No 1.00 (reference) 0.115 1.00 (reference) 0.064
 Yes 1.55 (0.90 to 2.69) 1.69 (0.97 to 2.95)

*p<0.05, **p<0.01, ***p<0.001.

†Model 1: Unadjusted.

‡Model 2: Adjusted for age, ethnicity, education level, marital status, residence, smoking status, alcohol drinking status, waist circumference and physical activity (association of sleep problems) or sleep problems (association of physical activity).

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.

Joint effects of sleep and PA on the risk of dyslipidaemia and its components

The participants were categorised into six subgroups according to their joint PA and sleep characteristics. After adjustment for confounders, the joint effects of PA and sleep on dyslipidaemia were significant. Women with sleep problems had higher risk of dyslipidaemia than women without sleep problems, irrespective of low, moderate or high PA, with OR (95% CI) of 4.24 (2.40 to 7.49), 3.14 (1.80 to 5.49) and 2.04 (1.20 to 3.48), respectively, (figure 1). PA could not completely attenuate the negative association between sleep problems and risk of dyslipidaemia. With PA increased from low to high, the OR of dyslipidaemia decreased by 2.20 (table 4).

Figure 1.

Figure 1

The simple effect of sleep with dyslipidaemia. PA, physical activity.

Table 4.

The ΔOR of the dyslipidaemia and its components in women with sleep problems

Sleep problems Physical activity ΔOR
Low OR (95% CI) Moderate OR (95% CI) High OR (95% CI)
Dyslipidaemia Yes 4.24 (2.40 to 7.49)* 3.14 (1.80 to 5.49)* 2.04 (1.20 to 3.48)* 2.20
No 1.73 (0.92 to 3.24) 1.58 (0.83 to 2.98) 1.00 (reference)
High TC Yes 2.51 (1.18 to 5.35)* 1.65 (0.75 to 3.60) 0.79 (0.34 to 1.83) 1.72
No 0.65 (0.22 to 1.94) 0.76 (0.27 to 2.16) 1.00 (reference)
High TG Yes 2.42 (1.23 to 4.74)* 1.87 (0.94 to 3.71) 1.56 (0.80 to 3.01) 0.86
No 1.05 (0.47 to 2.37) 1.49 (0.68 to 3.24) 1.00 (reference)
Low HDL-C Yes 2.88 (1.44 to 5.74)* 2.08 (1.03 to 4.20)* 1.97 (1.01 to 3.84)* 0.91
No 2.12 (1.00 to 4.49) 2.00 (0.92 to 4.31) 1.00 (reference)
High LDL-C Yes 2.52 (1.12 to 5.70)* 1.52 (0.64 to 3.62) 0.78 (0.32 to 1.92) 1.74
No 0.74 (0.24 to 2.25) 0.78 (0.25 to 2.38) 1.00 (reference)

*p<0.05.

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.

Likewise, women with sleep problems and low PA had higher risks of high TC, high TG, low HDL-C and high LDL-C than women without sleep problems and high PA, with OR (95% CI) of 2.51 (1.18 to 5.35), 2.42 (1.23 to 4.74), 2.88 (1.44 to 5.74) and 2.52 (1.12 to 5.70), respectively. With PA increased from low to high, the OR of low HDL-C decreased by 0.91 (table 4). Sleep problems were associated with increased risks of dyslipidaemia (OR=3.14; 95% CI: 1.80 to 5.49) and low HDL-C (OR=2.08; 95% CI: 1.03 to 4.20) among women with moderate PA. In addition, high PA was associated with increased risk of low HDL-C (OR=1.97; 95% CI: 1.01 to 3.84) among women with sleep problems (figure 2A–D).

Figure 2.

Figure 2

The simple effect of sleep with the components of dyslipidaemia; (A) TC, total cholesterol; (B) TG, triglyceride; (C) HDL-C, high-density lipoprotein cholesterol; (D) LDL-C, low-density lipoprotein cholesterol. PA, physical activity.

Discussion

In the present study, the prevalence of dyslipidaemia was 41.1% in women aged 45–55 years, 60.6% of participants had sleep problems and 29.0% participants had low PA. The prevalence of dyslipidaemia was 47.4% in women with sleep problems, and significantly higher than that in women without sleep problems.

Low PA and sleep problems were interactively associated with an increased risk of dyslipidaemia in women aged 45–55 years. Furthermore, the effects on dyslipidaemia were more marked for sleep than for PA. We found that PA attenuated but did not eliminate the excess risk of dyslipidaemia associated with sleep problems. With PA increased from low to high, the OR of dyslipidaemia and low HDL-C decreased by 2.20 and 0.91, respectively.

Comparisons with other studies

Among middle-aged and older people, PA had significant positive associations with several health conditions, including reduced risks of cardiovascular disease,43 diabetes44 and hypertension.45 Our study showed that high PA was associated with lower risk of dyslipidaemia and its components, included high TC and high TG in women aged 45–55 years. In our study, self-reported sleep was measured by a questionnaire that contained all dimensions of the widely employed Pittsburgh Sleep Quality Index (PSQI), and clearly distinguished whether women had sleep problems. Consistent with our results, previous studies reported that sleep problems measured by the PSQI were associated with the increased risk of dyslipidaemia and its components.23 24

To date, epidemiological evidence regarding the joint effects of PA and sleep on dyslipidaemia has been limited. Casas et al35 reported that low leisure-time activity was negatively associated with high TC and low HDL-C. The study pointed out that the joint effects on serum lipids were more marked for leisure-time activity than for sleep quality. Contrary to their results, the effect on risk of dyslipidaemia were more marked for sleep than for PA in the present study. These discrepancies among the findings may be partly explained by differences in the measurement methods for PA and sleep quality. In our study, we measured PA by the GPAQ, which included occupational, transition and leisure-time PA, and used a questionnaire to assess sleep quality. Whereas Casas, et al only analysed the leisure-time PA, and measured sleep quality by PSQI. What is more, the women participants were aged 45–55 years, who were in the perimenopausal period accompanied by changes in hormone levels. Previous study showed that daily PA and energy expenditure significantly decreased during the perimenopausal period.46 Santoro showed that poor sleep quality became more common in perimenopausal women associated with the hormonal changes.47 Furthermore, with decreasing oestrogen levels, the risk of dyslipidaemia of perimenopausal women has increased significantly.15

There are several potential factors to address for the difference between the simple effects of sleep and PA on the risk of dyslipidaemia. Age was positively associated with risk of dyslipidaemia.9 48 In our study, women with sleep problems were older, and women with dyslipidaemia were also older. Alcohol drinking has been suggested as a possible risk factor for dyslipidaemia.49 50 In our study, women with sleep problems were more likely to drink alcohol, which may be another reason why sleep problems had a greater effect on dyslipidaemia.

Our results were consistent with previous studies regarding the interactive associations of sleep and PA with chronic pain,51 somatic symptoms,52 insulin resistance53 and depressive symptoms.54 All of these studies highlighted the health benefits of PA and suggested that any adverse effects of sleep problems on those outcomes may be reduced by regular PA. In our study, with PA increased from low to high, the OR of dyslipidaemia decreased by 2.20. Meanwhile, contrary to other studies,32 33 there was no significant association between PA and sleep problems, suggesting that increasing PA may not improve sleep quality in middle-aged women.

Modifiable PA has an effective protection on human’s health against chronic diseases55–57 especially in participants with sleep problems, even if PA did not completely counteract the risk among sleep problems individuals. Modifiable PA are widely accessible and effective intervention to reduce the risk of dyslipidaemia and other chronic diseases in women with sleep problems, especially in perimenopausal women.

Strengths and limitations

Our study has some strengths and limitations. To our knowledge, there were relatively few studies on the joint effects of sleep and PA on risk of dyslipidaemia. This study was based on a survey of chronic disease and nutrition in Chinese adults, covered urban, agricultural and pastoral areas in Inner Mongolia. The participants were recruited consecutively used multistage cluster random sampling, which were generally representative. However, our study was a cross-sectional study, which only showed the relationship between sleep, PA and the risk of dyslipidaemia, not the causal association. In our study, self-reported sleep was measured by a questionnaire that included five questions. Although, these five questions consist all dimensions of the widely employed PSQI, there were some biases in our results due to no special scale used. Therefore, it is necessary to conduct more prospective and experimental research on the joint effects of sleep and PA on the risk of dyslipidaemia in women in the perimenopausal period.

Conclusions

In women aged 45–55 years, the joint effects of self-reported sleep and PA on risk of dyslipidaemia were more marked for sleep than for PA. Women aged 45–55 years with sleep problems and low PA should be given more attention. Modifiable PA is a widely accessible and effective intervention to reduce the risk of dyslipidaemia in women with sleep problems, particularly among women during the perimenopausal period. The study can provide some effective suggestions for the management of dyslipidaemia in perimenopausal women. Further research is warranted to identify available services for perimenopausal women to improve their quality of life.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We thank all participants and investigators for the Chronic Disease and Nutrition Monitoring in Adults in Inner Mongolia in 2015. We also thank Min Yang and Yanling Wang for their contributions to the article, they contributed to revising the manuscript and providing some useful suggestions for review.

Footnotes

SD and YS contributed equally.

Contributors: XW contributed to conceiving the study concept and design and was responsible for the overall content as the guarantor. SD and YS analysed the data and wrote the first draft of the paper. All authors (SD, YS, DZ, JW, HZ and XW) contributed to the interpretation of data and were involved revising the manuscript critically for important intellectual content. All authors gave a final approval of the version to be published and agreed to be accountable for all aspects of the work. The authors declared that they had no conflict of interests.

Funding: This study was supported by the National Natural Science Foundation of China, grant number 81960603. (Study on the Mechanism of NAMPT Regulated by Hyperglycemia and CpnT Promoting Macrophage Death in Diabetes with Pulmonary Tuberculosis Infection.)

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement

No data are available.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

The Chronic Disease and Nutrition Monitoring in Adults in 2015 programme protocols were approved by the Ethical Committee of the National Institute for Chinese Center for Disease Control and Prevention (201519-A). Participants gave informed consent to participate in the study before taking part.

References

  • 1.Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78. 10.1016/S0140-6736(05)67394-1 [DOI] [PubMed] [Google Scholar]
  • 2.Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care 2013;40:195–211. 10.1016/j.pop.2012.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.GBD 2017 Risk Factor Collaborators . Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1923–94. 10.1016/S0140-6736(18)32225-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang M, Zhou J, Liu Y, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: the rural Chinese cohort study. Diabetes Res Clin Pract 2018;135:150–7. 10.1016/j.diabres.2017.11.011 [DOI] [PubMed] [Google Scholar]
  • 5.Zhao Q, Li J, Yang J, et al. Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure. Medicine 2017;96:e6094. 10.1097/MD.0000000000006094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143–421. [PubMed] [Google Scholar]
  • 7.Ebrahimi H, Emamian MH, Hashemi H, et al. Dyslipidemia and its risk factors among urban middle-aged Iranians: a population-based study. Diabetes Metab Syndr 2016;10:149–56. 10.1016/j.dsx.2016.01.009 [DOI] [PubMed] [Google Scholar]
  • 8.Stevenson JC, Chines A, Pan K, et al. A pooled analysis of the effects of conjugated estrogens/bazedoxifene on lipid parameters in postmenopausal women from the selective estrogens, menopause, and response to therapy (SMART) trials. J Clin Endocrinol Metab 2015;100:2329–3238. 10.1210/jc.2014-2649 [DOI] [PubMed] [Google Scholar]
  • 9.Wu H, Xiong L, Xu Q, et al. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis 2015;25:749–55. 10.1016/j.numecd.2015.05.006 [DOI] [PubMed] [Google Scholar]
  • 10.Wang Z, Wang D, Wang Y. Cigarette smoking and adipose tissue: the emerging role in progression of atherosclerosis. Mediators Inflamm 2017;2017:3102737. 10.1155/2017/3102737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Donley DA, Fournier SB, Reger BL, et al. Aerobic exercise training reduces arterial stiffness in metabolic syndrome. J Appl Physiol 2014;116:1396–404. 10.1152/japplphysiol.00151.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nelson HD. Menopause. Lancet 2008;371:760–70. 10.1016/S0140-6736(08)60346-3 [DOI] [PubMed] [Google Scholar]
  • 13.Li L, Wu J, Pu D, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas 2012;73:354–60. 10.1016/j.maturitas.2012.09.008 [DOI] [PubMed] [Google Scholar]
  • 14.Chinese College of Cardiovascular Physician Women Physician Committee, Chinese Society of Cardiology Women’s Heart Health Group . [Chinese expert consensus on management of dyslipidemia in postmenopausal women]. Zhonghua Xin Xue Guan Bing Za Zhi 2014;42:279–83. [PubMed] [Google Scholar]
  • 15.Cortez-Dias N, Robalo Martins S, Belo A, et al. Em nome DOS Investigadores do Estudo VALSIM. Characterization of lipid profile in primary health care users in Portugal. Rev Port Cardiol 2013;32:987–96. [DOI] [PubMed] [Google Scholar]
  • 16.Li Y, Zhao L, Yu D, et al. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. PLoS One 2018;13:e0205709. 10.1371/journal.pone.0205709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sagayadevan V, Abdin E, Binte Shafie S, et al. Prevalence and correlates of sleep problems among elderly Singaporeans. Psychogeriatrics 2017;17:43–51. 10.1111/psyg.12190 [DOI] [PubMed] [Google Scholar]
  • 18.Bruyneel M. Sleep disturbances in menopausal women: aetiology and practical aspects. Maturitas 2015;81:406–9. 10.1016/j.maturitas.2015.04.017 [DOI] [PubMed] [Google Scholar]
  • 19.Boyle A, Melville CA, Morrison J, et al. A cohort study of the prevalence of sleep problems in adults with intellectual disabilities. J Sleep Res 2010;19:42–53. 10.1111/j.1365-2869.2009.00788.x [DOI] [PubMed] [Google Scholar]
  • 20.Harvey MT, Baker DJ, Horner RH, et al. A brief report on the prevalence of sleep problems in individuals with mental retardation living in the community. J Posit Behav Interv 2003;5:195–200. 10.1177/10983007030050040201 [DOI] [Google Scholar]
  • 21.Hung C-M, Li Y-C, Chen H-J, et al. Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study. BMC Psychiatry 2018;18:38. 10.1186/s12888-018-1623-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Medic G, Wille M, Hemels ME. Short- and long-term health consequences of sleep disruption. Nat Sci Sleep 2017;9:151–61. 10.2147/NSS.S134864 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wan Mahmood WA, Draman Yusoff MS, Behan LA, et al. Association between sleep disruption and levels of lipids in caucasians with type 2 diabetes. Int J Endocrinol 2013;2013:341506. 10.1155/2013/341506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hung H-C, Yang Y-C, Ou H-Y, et al. The association between self-reported sleep quality and metabolic syndrome. PLoS One 2013;8:e54304. 10.1371/journal.pone.0054304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Takahashi TA, Johnson KM. Menopause. Med Clin North Am 2015;99:521–34. 10.1016/j.mcna.2015.01.006 [DOI] [PubMed] [Google Scholar]
  • 26.Liu X, Yu S, Mao Z, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis 2018;17:119. 10.1186/s12944-018-0768-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nybo L, Sundstrup E, Jakobsen MD, et al. High-intensity training versus traditional exercise interventions for promoting health. Med Sci Sports Exerc 2010;42:1951–8. 10.1249/MSS.0b013e3181d99203 [DOI] [PubMed] [Google Scholar]
  • 28.LeMura LM, von Duvillard SP, Andreacci J, et al. Lipid and lipoprotein profiles, cardiovascular fitness, body composition, and diet during and after resistance, aerobic and combination training in young women. Eur J Appl Physiol 2000;82:451–8. 10.1007/s004210000234 [DOI] [PubMed] [Google Scholar]
  • 29.Kokkinos PF, Faselis C, Myers J, et al. Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study. Lancet 2013;381:394–9. 10.1016/S0140-6736(12)61426-3 [DOI] [PubMed] [Google Scholar]
  • 30.Christie AD, Seery E, Kent JA. Physical activity, sleep quality, and self-reported fatigue across the adult lifespan. Exp Gerontol 2016;77:exger.2016.02.001:7–11. 10.1016/j.exger.2016.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Borges-Cosic M, Aparicio VA, Estévez-López F, et al. Sedentary time, physical activity, and sleep quality in fibromyalgia: the al-Ándalus project. Scand J Med Sci Sports 2019;29:266–74. 10.1111/sms.13318 [DOI] [PubMed] [Google Scholar]
  • 32.Štefan L, Vrgoč G, Rupčić T, et al. Sleep duration and sleep quality are associated with physical activity in elderly people living in nursing homes. Int J Environ Res Public Health 2018;15:2512. 10.3390/ijerph15112512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Štefan L, Sporiš G, Krističević T, et al. Associations between sleep quality and its domains and insufficient physical activity in a large sample of Croatian young adults: a cross-sectional study. BMJ Open 2018;8:e021902. 10.1136/bmjopen-2018-021902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Porter VR, Buxton WG, Avidan AY. Sleep, cognition and dementia. Curr Psychiatry Rep 2015;17:97. 10.1007/s11920-015-0631-8 [DOI] [PubMed] [Google Scholar]
  • 35.Casas RS, Pettee Gabriel KK, Kriska AM, et al. Association of leisure physical activity and sleep with cardiovascular risk factors in postmenopausal women. Menopause 2012;19:413–9. 10.1097/gme.0b013e318230f531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Pang SJ. Associations of lipid parameters and phospholipid profiles with insulin resistance among adults. Chinese Center for Diseases Control and Prevention 2018. [Google Scholar]
  • 37.Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med 2017;167:ITC81–96. 10.7326/AITC201712050 [DOI] [PubMed] [Google Scholar]
  • 38.Olinto MTA, Garcez A, Henn RL, et al. Sleep-related problems and minor psychiatric disorders among Brazilian shift workers. Psychiatry Res 2017;257:412–7. 10.1016/j.psychres.2017.08.018 [DOI] [PubMed] [Google Scholar]
  • 39.World Health Organization . Global physical activity questionnaire (GPAQ). Available: https://www.who.int/ncds/surveillance/steps/GPAQ_EN.pdf
  • 40.World Health Organization . Global physical activity questionnaire (GPAQ) analysis guide. Available: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf
  • 41.Yu ZM, Parker L, Dummer TJB. Depressive symptoms, diet quality, physical activity, and body composition among populations in nova Scotia, Canada: report from the Atlantic partnership for tomorrow's health. Prev Med 2014;61:106–13. 10.1016/j.ypmed.2013.12.022 [DOI] [PubMed] [Google Scholar]
  • 42.Xu W, Zhang H, Paillard-Borg S, et al. Prevalence of overweight and obesity among Chinese adults: role of adiposity indicators and age. Obes Facts 2016;9:17–28. 10.1159/000443003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.de Souto Barreto P, Cesari M, Andrieu S, et al. Physical activity and incident chronic diseases: a longitudinal observational study in 16 European countries. Am J Prev Med 2017;52:373–8. 10.1016/j.amepre.2016.08.028 [DOI] [PubMed] [Google Scholar]
  • 44.Marques A, Peralta M, Sarmento H, et al. Associations between vigorous physical activity and chronic diseases in older adults: a study in 13 European countries. Eur J Public Health 2018;28:950–5. 10.1093/eurpub/cky086 [DOI] [PubMed] [Google Scholar]
  • 45.Huai P, Xun H, Reilly KH, et al. Physical activity and risk of hypertension: a meta-analysis of prospective cohort studies. Hypertension 2013;62:1021–6. 10.1161/HYPERTENSIONAHA.113.01965 [DOI] [PubMed] [Google Scholar]
  • 46.Kim J-S, Choe J-P, Park J-H, et al. The comparison of physical activity, sedentary behavior, and mental health between early menopausal women and age-matched General middle-aged women. Int J Environ Res Public Health 2021;18:7256. 10.3390/ijerph18147256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Santoro N. Perimenopause: from research to practice. J Women Health 2002;25:332–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Florez H, Silva E, Fernández V, et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in white, black, Amerindian and mixed Hispanics in Zulia state, Venezuela. Diabetes Res Clin Pract 2005;69:63–77. 10.1016/j.diabres.2004.11.018 [DOI] [PubMed] [Google Scholar]
  • 49.Pintó X, Valdivielso P, Perez de Juan JM, et al. Predictive factors of achieving therapeutic goals of hypertriglyceridemia. Curr Med Res Opin 2014;30:19–26. 10.1185/03007995.2013.850069 [DOI] [PubMed] [Google Scholar]
  • 50.Yang J, Ye J, Guo Q, et al. The joint effects of smoking and alcohol drinking on lipid-related indices among Chinese males-comparing exercise and non-exercise groups. Subst Use Misuse 2018;53:2431–8. 10.1080/10826084.2018.1482347 [DOI] [PubMed] [Google Scholar]
  • 51.Mork PJ, Vik KL, Moe B, et al. Sleep problems, exercise and obesity and risk of chronic musculoskeletal pain: the Norwegian HUNT study. Eur J Public Health 2014;24:924–9. 10.1093/eurpub/ckt198 [DOI] [PubMed] [Google Scholar]
  • 52.Ablin JN, Clauw DJ, Lyden AK, et al. Effects of sleep restriction and exercise deprivation on somatic symptoms and mood in healthy adults. Clin Exp Rheumatol 2013;31:S53–9. [PubMed] [Google Scholar]
  • 53.Zuo H, Shi Z, Yuan B, et al. Interaction between physical activity and sleep duration in relation to insulin resistance among non-diabetic Chinese adults. BMC Public Health 2012;12:247. 10.1186/1471-2458-12-247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kaseva K, Dobewall H, Yang X, et al. Physical activity, sleep, and symptoms of depression in Adults-Testing for mediation. Med Sci Sports Exerc 2019;51:1162–8. 10.1249/MSS.0000000000001896 [DOI] [PubMed] [Google Scholar]
  • 55.Dao-Tran T-H, Seib C. Prevalence and correlates of sleep disturbance among older women in Vietnam. J Clin Nurs 2018;27:3307–13. 10.1111/jocn.14080 [DOI] [PubMed] [Google Scholar]
  • 56.Andersson C, Lyass A, Larson MG, et al. Physical activity measured by accelerometry and its associations with cardiac structure and vascular function in young and middle-aged adults. J Am Heart Assoc 2015;4:e001528. 10.1161/JAHA.114.001528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Goto C, Higashi Y, Kimura M, et al. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003;108:530–5. 10.1161/01.CIR.0000080893.55729.28 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Data Availability Statement

No data are available.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES